Shanghai Haohai Biological Tech Co (688366)

Currency in CNY
54.84
-0.77(-1.39%)
Delayed Data·
688366 Scorecard
Full Analysis
Management has been aggressively buying back shares
688366 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
54.5955.99
52 wk Range
49.0589.27
Key Statistics
Bid/Ask
54.83 / 54.85
Prev. Close
55.61
Open
55.99
Day's Range
54.59-55.99
52 wk Range
49.05-89.27
Volume
991.4K
Average Volume (3m)
933.27K
1-Year Change
-7.79%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688366 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
72.00
Upside
+31.29%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Shanghai Haohai Biological Tech Co Company Profile

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel, anti-adhesion, and burn wound related products. In addition, it provides injectors, scalpels, suture needles and other products. Further, the company offers medical aesthetics products, including Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, it is involved in the research and development, consultation, and services of biological engineering and pharmaceutical products, and related technology transfer activities; manufacture and sale of biological reagents, biologicals, and biological materials; manufacture and sale of intraocular lens and related products; sale machines of medical aesthetics, professional life cosmetology, and home cosmetology; sale of ophthalmology products; and provision of other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Employees
2156
Market
China

Compare 688366 to Peers and Sector

Metrics to compare
688366
Peers
Sector
Relationship
P/E Ratio
27.9x40.0x−0.5x
PEG Ratio
−2.070.580.00
Price/Book
2.0x2.7x2.6x
Price / LTM Sales
4.3x7.3x3.3x
Upside (Analyst Target)
29.5%1.4%40.3%
Fair Value Upside
Unlock8.6%4.7%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 72.00
(+31.29% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.77%
Dividend Yield
1.80%
Industry Median 1.79%
Annualised payout
1.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.39 / --
Revenue / Forecast
618.54M / --
EPS Revisions
Last 90 days

688366 Income Statement

FAQ

What Stock Exchange Does Shanghai Haohai Trade On?

Shanghai Haohai is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Shanghai Haohai?

The stock symbol for Shanghai Haohai is "688366."

What Is the Shanghai Haohai Market Cap?

As of today, Shanghai Haohai market cap is 11.61B.

What Is Shanghai Haohai's Earnings Per Share (TTM)?

The Shanghai Haohai EPS (TTM) is 1.77.

When Is the Next Shanghai Haohai Earnings Date?

Shanghai Haohai will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 688366 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Shanghai Haohai Stock Split?

Shanghai Haohai has split 1 times.

How Many Employees Does Shanghai Haohai Have?

Shanghai Haohai has 2156 employees.

What is the current trading status of Shanghai Haohai (688366)?

As of 14 Aug 2025, Shanghai Haohai (688366) is trading at a price of 54.84, with a previous close of 55.61. The stock has fluctuated within a day range of 54.59 to 55.99, while its 52-week range spans from 49.05 to 89.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.